The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers DOI Creative Commons
Meriem Messaoudene, Stéphanie Ferreira,

Nathalie Saint-Lu

et al.

Nature Communications, Journal Year: 2024, Volume and Issue: 15(1)

Published: Sept. 15, 2024

Language: Английский

The gut microbiome and dietary fibres: implications in obesity, cardiometabolic diseases and cancer DOI
Nathalie M. Delzenne, Laure B. Bindels, Audrey M. Neyrinck

et al.

Nature Reviews Microbiology, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 10, 2024

Language: Английский

Citations

6

Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis DOI Creative Commons

Dashuang Sheng,

Chuandi Jin,

Kaile Yue

et al.

Cancer Letters, Journal Year: 2024, Volume and Issue: 598, P. 217077 - 217077

Published: June 20, 2024

The existence of microbiome in human tumors has been determined widely, but evaluating the contribution intratumoral bacteria and fungi to tumor immunity prognosis from a pan-cancer perspective remains absent. We designed an improved microbial analysis pipeline reduce interference host sequences, complemented with integration microbiota at species level clinical indicators, microenvironment, across cancer types. found that is associated immunophenotyping, high-immunity subtypes showing greater bacterial fungal richness compared low-immunity groups. also noted combination demonstrated promising prognostic value We, thus, present Cancer Microbiota (TCMbio), interactive platform provides data, comprehensive module for 33 types cancers. This led discovery significance microbes.

Language: Английский

Citations

5

Effects of gut microbiota on immune checkpoint inhibitors in multi-cancer and as microbial biomarkers for predicting therapeutic response DOI Creative Commons
Yufeng Lin, Mingxu Xie, Harry Cheuk-Hay Lau

et al.

Med, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 1, 2024

Gut bacteria are related to immune checkpoint inhibitors (ICIs). However, there is inconsistency in ICI-associated species, while the role of non-bacterial microbes immunotherapy remains elusive. Here, we evaluated association trans-kingdom with ICIs by multi-cohort multi-cancer analyses.

Language: Английский

Citations

5

Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targets DOI Creative Commons

Sara Tharwat Abdullah,

Snur Rasool Abdullah, Bashdar Mahmud Hussen

et al.

Non-coding RNA Research, Journal Year: 2023, Volume and Issue: 9(1), P. 236 - 252

Published: Dec. 15, 2023

Gastrointestinal cancers are a huge worldwide health concern, which includes wide variety of digestive tract cancers. Circular RNAs (circRNAs), kind non-coding RNA (ncRNAs), family single-stranded, covalently closed that have become recognized as crucial gene expression regulators, having an impact on several cellular functions in cancer biology. The gut microbiome, consists different bacteria, actively contributes to the regulation host immunity, inflammation, and metabolism. CircRNAs microbiome interact significantly greatly affect growth GI cancer. Several studies focus complex circRNAs microbiota cancers, including esophageal cancer, colorectal gastric hepatocellular pancreatic It also emphasizes how changed circRNA profiles pathways connected malignancy well hallmarks gastrointestinal Furthermore, been recommended biological markers for therapeutic targets diagnostic prognostic purposes. Targeting treatment is being continued study. Despite significant initiatives, connection between emergence remains poorly understood. In this study, we will go over most recent emphasize key roles progression options. order create effective therapies plan future therapy, it important comprehend mechanisms microbiota.

Language: Английский

Citations

11

The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers DOI Creative Commons
Meriem Messaoudene, Stéphanie Ferreira,

Nathalie Saint-Lu

et al.

Nature Communications, Journal Year: 2024, Volume and Issue: 15(1)

Published: Sept. 15, 2024

Language: Английский

Citations

4